{"papers":[{"id":5733,"title":"Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement","authors":"Pérez Rosal Sergio R., Faber Sonya C.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100029","pubmed_id":null,"openalex_id":"https://openalex.org/W7169607828","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","substance_tags":"psilocybin","topic_tags":"Observational Study","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-19 01:20:13","last_checked":"2026-08-09 08:28:45","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Prez2026p5733,\n  title = {Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement},\n  author = {Pérez Rosal Sergio R. and Faber Sonya C.},\n  journal = {Psychedelics},\n  year = {2026},\n  doi = {10.1016/j.psyche.2026.100029},\n  url = {https://doi.org/10.1016/j.psyche.2026.100029},\n}\n","source_record_id":"DOI:10.1016/j.psyche.2026.100029","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100029","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100029","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","doi":"10.1016/j.psyche.2026.100029","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3113,"title":"Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model","authors":"Albertyn Christopher P., Richard Jérémie, Shore Ron, Carlson Linda E.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100032","pubmed_id":null,"openalex_id":"https://openalex.org/W7171862645","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","substance_tags":"psilocybin","topic_tags":"Cancer Patients","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 11:03:46","last_checked":"2026-08-09 08:28:45","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Albertyn2026p3113,\n  title = {Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model},\n  author = {Albertyn Christopher P. and Richard Jérémie and Shore Ron and Carlson Linda E.},\n  journal = {Psychedelics},\n  year = {2026},\n  doi = {10.1016/j.psyche.2026.100032},\n  url = {https://doi.org/10.1016/j.psyche.2026.100032},\n}\n","source_record_id":"DOI:10.1016/j.psyche.2026.100032","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100032","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100032","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","doi":"10.1016/j.psyche.2026.100032","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5679,"title":"Pupil-DLC: An open-source deep learning pipeline for scalable, marker-less tracking of pupil dynamics across conscious and unconscious states.","authors":"Seyfourian P, Marks LC, Claar LD, Nahas Y, Keating M, Koch C, Rembado I","journal":"Journal of neuroscience methods","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1016/j.jneumeth.2026.110848","pubmed_id":"42401399","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Consciousness,Biomarkers,Aging,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-09 01:20:07","last_checked":"2026-08-09 08:27:44","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Seyfourian2026p5679,\n  title = {Pupil-DLC: An open-source deep learning pipeline for scalable, marker-less tracking of pupil dynamics across conscious and unconscious states.},\n  author = {Seyfourian P and Marks LC and Claar LD and Nahas Y and Keating M and Koch C and Rembado I},\n  journal = {Journal of neuroscience methods},\n  year = {2026},\n  doi = {10.1016/j.jneumeth.2026.110848},\n  url = {https://pubmed.ncbi.nlm.nih.gov/42401399/},\n  pmid = {42401399},\n}\n","source_record_id":"PMID:42401399","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42401399","source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","doi":"10.1016/j.jneumeth.2026.110848","pmid":"42401399","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":64,"title":"Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression","authors":"Kelly Carlton M., Fradet Mathieu, Bostian Catherine M., Donnelly Anna, Ellis Sara, Ostacher Michael, Aaronson Scott, Suppes Trisha","journal":"Journal of Affective Disorders","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1016/j.jad.2026.122063","pubmed_id":"42248535","openalex_id":"https://openalex.org/W7163510976","source_url":"https://doi.org/10.1016/j.jad.2026.122063","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Treatment-Resistant Depression,Veterans","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:45","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Kelly2026p64,\n  title = {Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression},\n  author = {Kelly Carlton M. and Fradet Mathieu and Bostian Catherine M. and Donnelly Anna and Ellis Sara and Ostacher Michael and Aaronson Scott and Suppes Trisha},\n  journal = {Journal of Affective Disorders},\n  year = {2026},\n  doi = {10.1016/j.jad.2026.122063},\n  url = {https://doi.org/10.1016/j.jad.2026.122063},\n  pmid = {42248535},\n}\n","source_record_id":"PMID:42248535","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.jad.2026.122063","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42248535","source_url":"https://doi.org/10.1016/j.jad.2026.122063","doi":"10.1016/j.jad.2026.122063","pmid":"42248535","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":302,"title":"Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats","authors":"Ladislavová Lucie, Kútná Viera, Mazochová Kristýna, Šíchová Klára, Danda Hynek, Lhotková Eva, Uttl Libor, Brejtr Vojtěch, Syrová Kateřina, Mazoch Vladimír, Horsley Rachel, Páleníček Tomáš","journal":"Pharmacology Biochemistry and Behavior","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.pbb.2026.174231","pubmed_id":"42379524","openalex_id":"https://openalex.org/W7166640155","source_url":"https://doi.org/10.1016/j.pbb.2026.174231","substance_tags":"psilocin","topic_tags":"Neurogenesis,Microdosing","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:48:03","last_checked":"2026-08-09 08:28:49","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Ladislavov2026p302,\n  title = {Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats},\n  author = {Ladislavová Lucie and Kútná Viera and Mazochová Kristýna and Šíchová Klára and Danda Hynek and Lhotková Eva and Uttl Libor and Brejtr Vojtěch and Syrová Kateřina and Mazoch Vladimír and Horsley Rachel and Páleníček Tomáš},\n  journal = {Pharmacology Biochemistry and Behavior},\n  year = {2026},\n  doi = {10.1016/j.pbb.2026.174231},\n  url = {https://doi.org/10.1016/j.pbb.2026.174231},\n  pmid = {42379524},\n}\n","source_record_id":"PMID:42379524","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.pbb.2026.174231","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42379524","source_url":"https://doi.org/10.1016/j.pbb.2026.174231","doi":"10.1016/j.pbb.2026.174231","pmid":"42379524","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":120,"title":"Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults","authors":"Yang Kevin H., Satybaldiyeva Nora, Kepner Wayne, Friedman Joseph, Ping Siyuan, Leas Eric C.","journal":"American Journal of Preventive Medicine","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.amepre.2026.108381","pubmed_id":"42092643","openalex_id":"https://openalex.org/W7160017394","source_url":"https://doi.org/10.1016/j.amepre.2026.108381","substance_tags":"psilocybin","topic_tags":"Microdosing","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:45","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Yang2026p120,\n  title = {Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults},\n  author = {Yang Kevin H. and Satybaldiyeva Nora and Kepner Wayne and Friedman Joseph and Ping Siyuan and Leas Eric C.},\n  journal = {American Journal of Preventive Medicine},\n  year = {2026},\n  doi = {10.1016/j.amepre.2026.108381},\n  url = {https://doi.org/10.1016/j.amepre.2026.108381},\n  pmid = {42092643},\n}\n","source_record_id":"PMID:42092643","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.amepre.2026.108381","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42092643","source_url":"https://doi.org/10.1016/j.amepre.2026.108381","doi":"10.1016/j.amepre.2026.108381","pmid":"42092643","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5961,"title":"Worsening of Depression and Anxiety With Psilocybin","authors":"Ghaemi S. Nassir","journal":"The Journal of Clinical Psychiatry","publication_date":"2026-09-30","publication_year":2026,"doi":"10.4088/jcp.26cr16608","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.4088/jcp.26cr16608","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-09-30 01:20:19","last_checked":"2026-09-30 01:20:19","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Ghaemi2026p5961,\n  title = {Worsening of Depression and Anxiety With Psilocybin},\n  author = {Ghaemi S. Nassir},\n  journal = {The Journal of Clinical Psychiatry},\n  year = {2026},\n  doi = {10.4088/jcp.26cr16608},\n  url = {https://doi.org/10.4088/jcp.26cr16608},\n}\n","source_record_id":"DOI:10.4088/jcp.26cr16608","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.4088/jcp.26cr16608","source_url":"https://doi.org/10.4088/jcp.26cr16608","doi":"10.4088/jcp.26cr16608","pmid":"","publication_date":"2026-09-30","importer_version":"2.1.3","text_redistributed":false}},{"id":5963,"title":"Reduced egocentricity after psilocybin in patients with alcohol use disorder: a pilot randomized controlled trial","authors":"Bukowski, H.; de Timary, P.; Belahda, D.; Igounenc, N.; Mura, T.; Serrand, C.; Luquiens, A.","journal":"medRxiv","publication_date":"2026-09-29","publication_year":2026,"doi":"10.64898/2026.09.26.26364086","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.09.26.26364086","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Mechanism of Action,Clinical Trial,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-09-30 01:20:46","last_checked":"2026-09-30 01:20:46","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Bukowski2026p5963,\n  title = {Reduced egocentricity after psilocybin in patients with alcohol use disorder: a pilot randomized controlled trial},\n  author = {Bukowski and H.; de Timary and P.; Belahda and D.; Igounenc and N.; Mura and T.; Serrand and C.; Luquiens and A.},\n  journal = {medRxiv},\n  year = {2026},\n  doi = {10.64898/2026.09.26.26364086},\n  url = {https://doi.org/10.64898/2026.09.26.26364086},\n}\n","source_record_id":"DOI:10.64898/2026.09.26.26364086","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.09.26.26364086","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.09.26.26364086","source_url":"https://doi.org/10.64898/2026.09.26.26364086","doi":"10.64898/2026.09.26.26364086","pmid":"","publication_date":"2026-09-29","importer_version":"2.1.3","text_redistributed":false}},{"id":5962,"title":"Psilocybin in psychiatry: Current clinical evidence, mechanisms of action and translational perspectives. A literature review based on PubMed-indexed studies","authors":"Nadolski Bartosz, Poćwiardowski Wojciech, Łazarz Sonia, Gromniak-Haniecka Ewa","journal":"Pharmacotherapy in Psychiatry and Neurology","publication_date":"2026-09-29","publication_year":2026,"doi":"10.17219/fpn/237077","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.17219/fpn/237077","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Review Article","study_type":"Review Article","source_name":"Crossref","publication_status":"published","date_added":"2026-09-30 01:20:19","last_checked":"2026-09-30 01:20:19","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Nadolski2026p5962,\n  title = {Psilocybin in psychiatry: Current clinical evidence, mechanisms of action and translational perspectives. A literature review based on PubMed-indexed studies},\n  author = {Nadolski Bartosz and Poćwiardowski Wojciech and Łazarz Sonia and Gromniak-Haniecka Ewa},\n  journal = {Pharmacotherapy in Psychiatry and Neurology},\n  year = {2026},\n  doi = {10.17219/fpn/237077},\n  url = {https://doi.org/10.17219/fpn/237077},\n}\n","source_record_id":"DOI:10.17219/fpn/237077","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.17219/fpn/237077","source_url":"https://doi.org/10.17219/fpn/237077","doi":"10.17219/fpn/237077","pmid":"","publication_date":"2026-09-29","importer_version":"2.1.3","text_redistributed":false}},{"id":5960,"title":"Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMT","authors":"Simonsson Otto, Bradley Melissa, Black Joshua C., Rockhill Karilynn M., Monte Andrew A., Hendricks Peter S.","journal":"JAMA Network Open","publication_date":"2026-09-29","publication_year":2026,"doi":"10.1001/jamanetworkopen.2026.36756","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.1001/jamanetworkopen.2026.36756","substance_tags":"psilocybin","topic_tags":"Observational Study","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-09-30 01:20:19","last_checked":"2026-09-30 01:20:19","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Simonsson2026p5960,\n  title = {Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMT},\n  author = {Simonsson Otto and Bradley Melissa and Black Joshua C. and Rockhill Karilynn M. and Monte Andrew A. and Hendricks Peter S.},\n  journal = {JAMA Network Open},\n  year = {2026},\n  doi = {10.1001/jamanetworkopen.2026.36756},\n  url = {https://doi.org/10.1001/jamanetworkopen.2026.36756},\n}\n","source_record_id":"DOI:10.1001/jamanetworkopen.2026.36756","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1001/jamanetworkopen.2026.36756","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1001/jamanetworkopen.2026.36756","source_url":"https://doi.org/10.1001/jamanetworkopen.2026.36756","doi":"10.1001/jamanetworkopen.2026.36756","pmid":"","publication_date":"2026-09-29","importer_version":"2.1.3","text_redistributed":false}},{"id":5746,"title":"Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease","authors":"National Institute on Aging (NIA)","journal":"ClinicalTrials.gov","publication_date":"2026-09-29","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07721467","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Mitochondrial Function,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Older Adults,Safety,Adverse Events,Inflammation","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-24 01:25:24","last_checked":"2026-09-30 01:24:15","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{National2026p5746,\n  title = {Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease},\n  author = {National Institute on Aging (NIA)},\n  journal = {ClinicalTrials.gov},\n  year = {2026},\n  url = {https://clinicaltrials.gov/study/NCT07721467},\n}\n","source_record_id":"https://clinicaltrials.gov/study/NCT07721467","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07721467","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07721467","source_url":"https://clinicaltrials.gov/study/NCT07721467","doi":"","pmid":"","publication_date":"2026-09-29","importer_version":"2.1.3","text_redistributed":false}},{"id":3693,"title":"Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study","authors":"University of Wisconsin, Madison","journal":"ClinicalTrials.gov","publication_date":"2026-09-29","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07360301","substance_tags":"psilocybin","topic_tags":"Consciousness,Wellbeing,Psychological Flexibility","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-09-30 01:24:15","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{University2026p3693,\n  title = {Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study},\n  author = {University of Wisconsin and Madison},\n  journal = {ClinicalTrials.gov},\n  year = {2026},\n  url = {https://clinicaltrials.gov/study/NCT07360301},\n}\n","source_record_id":"https://clinicaltrials.gov/study/NCT07360301","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07360301","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07360301","source_url":"https://clinicaltrials.gov/study/NCT07360301","doi":"","pmid":"","publication_date":"2026-09-29","importer_version":"2.1.3","text_redistributed":false}},{"id":5945,"title":"Targeting the serotonin 1B receptor for the treatment of depression and anxiety.","authors":"Fleury S, Nautiyal KM.","journal":"Expert opinion on therapeutic targets","publication_date":"2026-09-28","publication_year":2026,"doi":"10.1080/14728222.2026.2738183","pubmed_id":"42766349","openalex_id":"https://openalex.org/W7213928055","source_url":"https://doi.org/10.1080/14728222.2026.2738183","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-22 01:20:05","last_checked":"2026-09-30 01:20:19","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Fleury2026p5945,\n  title = {Targeting the serotonin 1B receptor for the treatment of depression and anxiety.},\n  author = {Fleury S and Nautiyal KM.},\n  journal = {Expert opinion on therapeutic targets},\n  year = {2026},\n  doi = {10.1080/14728222.2026.2738183},\n  url = {https://doi.org/10.1080/14728222.2026.2738183},\n  pmid = {42766349},\n}\n","source_record_id":"PMID:42766349","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1080/14728222.2026.2738183","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42766349","source_url":"https://doi.org/10.1080/14728222.2026.2738183","doi":"10.1080/14728222.2026.2738183","pmid":"42766349","publication_date":"2026-09-28","importer_version":"2.1.3","text_redistributed":false}},{"id":5845,"title":"The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease","authors":"Yale University","journal":"ClinicalTrials.gov","publication_date":"2026-09-28","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07610369","substance_tags":"psilocybin","topic_tags":"Depression,Microdosing,Randomized Controlled Trial,Safety","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-08-09 10:12:43","last_checked":"2026-09-30 01:24:15","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Yale2026p5845,\n  title = {The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease},\n  author = {Yale University},\n  journal = {ClinicalTrials.gov},\n  year = {2026},\n  url = {https://clinicaltrials.gov/study/NCT07610369},\n}\n","source_record_id":"https://clinicaltrials.gov/study/NCT07610369","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07610369","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07610369","source_url":"https://clinicaltrials.gov/study/NCT07610369","doi":"","pmid":"","publication_date":"2026-09-28","importer_version":"2.1.3","text_redistributed":false}},{"id":5959,"title":"Psilocybin for Treatment-Resistant Major Depression: Efficacy, Safety and Therapeutic Mechanisms","authors":"Lea Julia Mertens","journal":null,"publication_date":"2026-09-24","publication_year":2026,"doi":"10.11588/heidok.00039377","pubmed_id":null,"openalex_id":"https://openalex.org/W7214153504","source_url":"https://doi.org/10.11588/heidok.00039377","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Mechanism of Action,Safety","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-26 01:20:21","last_checked":"2026-09-30 01:20:23","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Lea2026p5959,\n  title = {Psilocybin for Treatment-Resistant Major Depression: Efficacy, Safety and Therapeutic Mechanisms},\n  author = {Lea Julia Mertens},\n  year = {2026},\n  doi = {10.11588/heidok.00039377},\n  url = {https://doi.org/10.11588/heidok.00039377},\n}\n","source_record_id":"DOI:10.11588/heidok.00039377","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.11588/heidok.00039377","source_url":"https://doi.org/10.11588/heidok.00039377","doi":"10.11588/heidok.00039377","pmid":"","publication_date":"2026-09-24","importer_version":"2.1.3","text_redistributed":false}},{"id":5958,"title":"Age moderates the relationship between psychedelic use and mental health in naturalistic settings","authors":"Giammarco Di Gregorio, Basset Sophia, Harjot Manmohan, Warren C. Nixon, Amrutha Pogaku, Jing Zhou, David J. Sanderson, Michael L. Lengieza, Marco Bocchio","journal":"Scientific Reports","publication_date":"2026-09-24","publication_year":2026,"doi":"10.1038/s41598-026-68283-2","pubmed_id":null,"openalex_id":"https://openalex.org/W7204099123","source_url":"https://doi.org/10.1038/s41598-026-68283-2","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Chronic Pain,Aging,Longevity,Mystical Experience,Clinical Trial,Observational Study,Older Adults,Safety,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-09-26 01:20:21","last_checked":"2026-09-30 01:20:23","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Giammarco2026p5958,\n  title = {Age moderates the relationship between psychedelic use and mental health in naturalistic settings},\n  author = {Giammarco Di Gregorio and Basset Sophia and Harjot Manmohan and Warren C. Nixon and Amrutha Pogaku and Jing Zhou and David J. Sanderson and Michael L. Lengieza and Marco Bocchio},\n  journal = {Scientific Reports},\n  year = {2026},\n  doi = {10.1038/s41598-026-68283-2},\n  url = {https://doi.org/10.1038/s41598-026-68283-2},\n}\n","source_record_id":"DOI:10.1038/s41598-026-68283-2","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1038/s41598-026-68283-2","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1038/s41598-026-68283-2","source_url":"https://doi.org/10.1038/s41598-026-68283-2","doi":"10.1038/s41598-026-68283-2","pmid":"","publication_date":"2026-09-24","importer_version":"2.1.3","text_redistributed":false}},{"id":3705,"title":"Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study","authors":"Yale University","journal":"ClinicalTrials.gov","publication_date":"2026-09-24","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07449351","substance_tags":"psilocybin","topic_tags":"Depression,Brain Imaging,Mechanism of Action,Aging,Longevity,Microdosing,Wellbeing,Treatment-Resistant Depression,Safety","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-09-30 01:24:15","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Yale2026p3705,\n  title = {Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study},\n  author = {Yale University},\n  journal = {ClinicalTrials.gov},\n  year = {2026},\n  url = {https://clinicaltrials.gov/study/NCT07449351},\n}\n","source_record_id":"https://clinicaltrials.gov/study/NCT07449351","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07449351","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07449351","source_url":"https://clinicaltrials.gov/study/NCT07449351","doi":"","pmid":"","publication_date":"2026-09-24","importer_version":"2.1.3","text_redistributed":false}},{"id":3529,"title":"Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial","authors":"Centre for Addiction and Mental Health","journal":"ClinicalTrials.gov","publication_date":"2026-09-24","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06299319","substance_tags":"psilocybin","topic_tags":"Addiction,OCD,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Case Report,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-09-30 01:24:15","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Centre2026p3529,\n  title = {Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial},\n  author = {Centre for Addiction and Mental Health},\n  journal = {ClinicalTrials.gov},\n  year = {2026},\n  url = {https://clinicaltrials.gov/study/NCT06299319},\n}\n","source_record_id":"https://clinicaltrials.gov/study/NCT06299319","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06299319","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06299319","source_url":"https://clinicaltrials.gov/study/NCT06299319","doi":"","pmid":"","publication_date":"2026-09-24","importer_version":"2.1.3","text_redistributed":false}},{"id":3440,"title":"Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial","authors":"Brigham and Women's Hospital","journal":"ClinicalTrials.gov","publication_date":"2026-09-24","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07296094","substance_tags":"psilocybin","topic_tags":"Anxiety,Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Clinical Trial,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-09-30 01:24:15","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Brigham2026p3440,\n  title = {Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial},\n  author = {Brigham and Women's Hospital},\n  journal = {ClinicalTrials.gov},\n  year = {2026},\n  url = {https://clinicaltrials.gov/study/NCT07296094},\n}\n","source_record_id":"https://clinicaltrials.gov/study/NCT07296094","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07296094","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07296094","source_url":"https://clinicaltrials.gov/study/NCT07296094","doi":"","pmid":"","publication_date":"2026-09-24","importer_version":"2.1.3","text_redistributed":false}},{"id":5957,"title":"Psilocybin and Contrasting Musical Compositions: Effects on Music-Evoked Emotional Responses in Healthy Adults","authors":"Dojcanova, D.; Tyls, F.; Nikolic, M.; Novak, T.; Viktorin, V.; Bravermanova, A.; Viktorinova, M.; Androvicova, R.; Andrashko, V.; Korcak, J.; Zach, P.; Horacek, J.; Brunovsky, M.; Palenicek, T.","journal":"medRxiv","publication_date":"2026-09-23","publication_year":2026,"doi":"10.64898/2026.09.09.26362648","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.09.09.26362648","substance_tags":"psilocybin","topic_tags":"Emotional Processing,Healthy Volunteers,Drug Interactions","study_type":"Clinical Trial","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-09-26 01:20:17","last_checked":"2026-09-30 01:20:46","bibtex":"% Exported from Psilocybin Research Publication Tracker\n\n% Tracker site: https://psilocybin-research.com\n\n% Publication tracker: https://psilocybin-research.com/\n\n\n\n@article{Dojcanova2026p5957,\n  title = {Psilocybin and Contrasting Musical Compositions: Effects on Music-Evoked Emotional Responses in Healthy Adults},\n  author = {Dojcanova and D.; Tyls and F.; Nikolic and M.; Novak and T.; Viktorin and V.; Bravermanova and A.; Viktorinova and M.; Androvicova and R.; Andrashko and V.; Korcak and J.; Zach and P.; Horacek and J.; Brunovsky and M.; Palenicek and T.},\n  journal = {medRxiv},\n  year = {2026},\n  doi = {10.64898/2026.09.09.26362648},\n  url = {https://doi.org/10.64898/2026.09.09.26362648},\n}\n","source_record_id":"DOI:10.64898/2026.09.09.26362648","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.09.09.26362648","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.09.09.26362648","source_url":"https://doi.org/10.64898/2026.09.09.26362648","doi":"10.64898/2026.09.09.26362648","pmid":"","publication_date":"2026-09-23","importer_version":"2.1.3","text_redistributed":false}}],"limit":25,"offset":0}